LE WE PMID CA
Atherosclerosis (BASKET)4005Atherosklerose (allg)

ABCA1

AMP activated protein kinase

Angiogenesis

Anticoagulants (Coumarins Phenprocoumon Warfarin)

Anticoagulants

Apolipoprotein AI

Apolipoprotein CIII

Apoptosis

Atherosclerosis (BASKET)

Atherosclerosis (Carotids and Basilaris)

Autoantibodies Anti AGE

Autoantibodies Anti Lipoprotein

Autophagy

Bax

Blood vessels (Imaging)

Blood vessels (MRT)

Blood vessels (Physiology)

Buflomedil

Cardiovascular risk

CD36 FAT fatty acid translocase

Ceramide

Chaperone (Pharmacological)

Cholesterol

Cilostazole

COPD

Dendritic cell (Immunology)

Dendritic cell (Plasmacytoid)

Diabetes mellitus (Beta cell decay)

Efferocytosis

Ephx2

Epoxide hydrolase

Epoxyeicosatrienoic acid EET

ERS UFR (Diseases)

ERS UFR (Pharmacology)

ERS UFR (Toxikologie)

Fatty acids (saturated)

GADD153 CHOP

Glycocalyx

GSK3

Heart (Coronary heart disease BASKET)

Heart (Coronary heart disease Main stenosis)

IGF1

Imaging (Molecular)

Inflammation resolution

iNOS

Interleukin17

Interleukin24 MDA7

Lipoprotein (HDL)

Lipoprotein (OxLDL)

Lipoprotein a

Lipoprotein associated phospholipase A2

Macrophages

MCP1 Monocyte chemotactic protein1

MCPIP

MRT (Contrast agents MRT)

NADPH oxidase

Nanomedicine

Neurodegeneration

Nitric oxide NO

Nitric oxide synthetase iNOS eNOS

Obesity (BASKET)

ORAI1 CRACM1

Osteocalcin

Redox (BASKET)

Renal artery stenosis

Rho kinase

SERCA

SIRT1

Smooth muscle

STIM1

Tauroursodeoxycholic acid ttchemchaperone

Tempol

Tetrahydrobiopterin

Thrombosis (BASKET)

TLR2

Toll like receptor

Valproic acid

Vasculitis (BASKET)

YKL40

2010  
1
2006  
2
Duplex ultrasound criteria for femorofemoral bypass revision.
[16950423] J Vasc Surg 44(3): 496-502 (2006)
2002  
3
Pharmacologic therapy for peripheral arterial disease and claudication.
[12469066] J Vasc Surg 36(6): 1283-91 (2002)
2009  
4
Endovascular management of chronic infrarenal aortic occlusion.
[19281286] J Endovasc Ther 16(1): 84-92 (2009)
2007  
5
Role of clopidogrel in managing atherothrombotic cardiovascular disease.
[17371888] Ann Intern Med 146(6): 434-41 (2007)
2007  
6
Screening for carotid artery stenosis: an update of the evidence for the U.S. Preventive Services Task Force.
[18087057] Ann Intern Med 147(12): 860-70 (2007)
2007  
7
Screening for carotid artery stenosis: U.S. Preventive Services Task Force recommendation statement.
[18087056] Ann Intern Med 147(12): 854-9 (2007)
1995  
8
Noninvasive carotid artery testing. A meta-analytic review.
[7847648] Ann Intern Med 122(5): 360-7 (1995)
2008  
9
Carotid plaque computed tomography imaging in stroke and nonstroke patients.
[18756475] Ann Neurol 64(2): 149-57 (2008)
2007  
10
Real-world replication of randomized controlled trial results for carotid endarterectomy.
[17923633] Arch Neurol 64(10): 1496-500 (2007)
2006  
11
Results of the management of atherothrombosis with clopidogrel in high-risk patients trial: implications for the neurologist.
[16401733] Arch Neurol 63(1): 20-4 (2006)
2004  
12
Diffusion-weighted magnetic resonance imaging in internal carotid artery dissection.
[15096398] Arch Neurol 61(4): 510-2 (2004)
2004  
13
Basilar occlusive disease: the descent of the feared foe?
[15096392] Arch Neurol 61(4): 471-2 (2004)
2002  
14
Spontaneous intracranial internal carotid artery dissection: report of 10 patients.
[12056934] Arch Neurol 59(6): 977-81 (2002)
2001  
15
Angioplasty or stenting is not appropriate as first-line treatment of intracranial stenosis.
[11594932] Arch Neurol 58(10): 1690-2 (2001)
2001  
16
Stroke with internal carotid artery stenosis.
[11295991] Arch Neurol 58(4): 605-9 (2001)
2000  
17
Carotid endarterectomy: a neurotherapeutic advance.
[10634431] Arch Neurol 57(1): 40-5 (2000)
2008  
18
Role of carotid duplex imaging in carotid screening programmes - an overview.
[18601737] Cardiovasc Ultrasound 6(): 34 (2008)
2008  
19
Atherosclerotic Peripheral Vascular Disease Symposium II: controversies in carotid artery revascularization.
[19106407] Circulation 118(25): 2852-9 (2008)
2007  
20
The argument to support broader application of extracranial carotid artery stent technology.
[17909116] Circulation 116(14): 1602-10; discussion 1610 (2007)
2007  
21
Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis.
[17242284] Circulation 115(4): 459-67 (2007)
2006  
22
Realizing the potential of carotid artery stenting: proposed paradigms for patient selection and procedural technique.
[16636190] Circulation 113(16): 2021-30 (2006)
1995  
23
Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the Ad Hoc Committee, American Heart Association.
[7805271] Circulation 91(2): 566-79 (1995)
2008  
24
Bifurcation lesions: a never-ending challenge.
[19001471] Eur Heart J 29(23): 2831-2 (2008)
2008  
25
Symptomatic carotid artery stenosis: the dilemma for a reasonable selection of carotid stenting or endarterectomy.
[18167365] Eur Heart J 29(1): 7-9 (2008)
2008  
26
Safety of carotid artery stenting for symptomatic carotid artery disease: a meta-analysis.
[17881346] Eur Heart J 29(1): 113-9 (2008)
2003  
27
Carotid artery stenting.
[12860884] Heart 89(8): 944-8 (2003)
2005  
28
Cerebral revascularisation: where are we now?
[15774426] J Neurol Neurosurg Psychiatry 76(4): 463-5 (2005)
1999  
29
1995  
30
Imaging blood vessels of the head and neck.
[7673947] J Neurol Neurosurg Psychiatry 59(3): 225-37 (1995)
1993  
31
Cranial nerve palsies in spontaneous carotid artery dissection.
[8229030] J Neurol Neurosurg Psychiatry 56(11): 1191-9 (1993)
2009  
32
Treatment of carotid artery stenosis: medical therapy, surgery, or stenting?
[19339655] Mayo Clin Proc 84(4): 362-87; quiz 367-8 (2009)
2007  
33
Diagnosis and invasive management of carotid atherosclerotic stenosis.
[17605967] Mayo Clin Proc 82(7): 851-8 (2007)
2007  
34
Antiplatelet therapy for atherothrombotic disease: an update for the primary care physician.
[17511957] Mayo Clin Proc 82(5): 583-93 (2007)
2006  
35
Platelets in atherothrombosis.
[16438480] Mayo Clin Proc 81(1): 59-68 (2006)
2004  
36
Carotid revascularization for prevention of stroke: carotid endarterectomy and carotid artery stenting.
[15357045] Mayo Clin Proc 79(9): 1197-208 (2004)
2004  
37
Evaluation and management of asymptomatic carotid artery stenosis.
[15244395] Mayo Clin Proc 79(7): 937-44 (2004)
2005  
38
Carotid and vertebral artery dissection syndromes.
[15937204] Postgrad Med J 81(956): 383-8 (2005)
1998  
39
Angioplasty and stenting in the carotid and vertebral arteries.
[9538479] Postgrad Med J 74(867): 7-10 (1998)
2008  
40
The role of carotid artery stenting and carotid endarterectomy in cognitive performance: a systematic review.
[18723423] Stroke 39(11): 3116-27 (2008)
2008  
41
Diagnostic accuracy of magnetic resonance angiography for internal carotid artery disease: a systematic review and meta-analysis.
[18556586] Stroke 39(8): 2237-48 (2008)
2008  
42
New brain lesions after carotid stenting versus carotid endarterectomy: a systematic review of the literature.
[18388346] Stroke 39(6): 1911-9 (2008)
2007  
43
Emerging endovascular therapies for symptomatic intracranial atherosclerotic disease.
[17585085] Stroke 38(8): 2391-6 (2007)
2007  
44
Stenting for middle cerebral artery stenosis: inevitable but when and how.
[17332460] Stroke 38(4): 1422 (2007)
2007  
45
Carotid stenting for asymptomatic carotid stenosis: trial it.
[17261723] Stroke 38(2 Suppl): 715-20 (2007)
2007  
46
Endarterectomy and stenting for asymptomatic carotid stenosis: a race at breakneck speed.
[17261722] Stroke 38(2 Suppl): 707-14 (2007)
2007  
47
Intra-arterial thrombolysis for basilar artery thrombosis: trial it.
[17261721] Stroke 38(2 Suppl): 704-6 (2007)
2007  
48
Intra-arterial thrombolytic therapy for acute basilar occlusion: pro.
[17261720] Stroke 38(2 Suppl): 701-3 (2007)
2007  
49
Intracranial hemorrhage associated with revascularization therapies.
[17234988] Stroke 38(2): 431-40 (2007)
2006  
50
Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation.
[16960090] Stroke 37(10): 2562-6 (2006)
2005  
51
The vulnerable carotid artery plaque: current imaging methods and new perspectives.
[16282537] Stroke 36(12): 2764-72 (2005)
2005  
52
Low-grade carotid stenosis: looking beyond the lumen with MRI.
[16239630] Stroke 36(11): 2504-13 (2005)
2005  
53
Endovascular revascularization of symptomatic acute extracranial internal carotid artery occlusion.
[16239628] Stroke 36(11): 2335-6 (2005)
2005  
54
Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients.
[16179564] Stroke 36(10): 2072-6 (2005)
2005  
55
Improved perioperative outcomes from carotid endarterectomy: yet another statin side effect?
[16179560] Stroke 36(10): 2058-9 (2005)
2005  
56
A systematic review of the risk factors for cervical artery dissection.
[15933263] Stroke 36(7): 1575-80 (2005)
2005  
57
A critical appraisal of the performance, reporting, and interpretation of studies comparing carotid plaque imaging with histology.
[15774817] Stroke 36(5): 1091-7 (2005)
2005  
58
Safety and efficacy of endovascular treatment of carotid artery stenosis compared with carotid endarterectomy: a Cochrane systematic review of the randomized evidence.
[15746454] Stroke 36(4): 905-11 (2005)
2005  
59
Systematic review of early recurrent stenosis after carotid angioplasty and stenting.
[15625299] Stroke 36(2): 367-73 (2005)
2004  
60
Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis.
[15514180] Stroke 35(12): 2902-9 (2004)
2004  
61
Systematic review of computed tomographic angiography for assessment of carotid artery disease.
[15345798] Stroke 35(10): 2306-12 (2004)
2004  
62
Reporting standards for carotid artery angioplasty and stent placement.
[15105523] Stroke 35(5): e112-34 (2004)
2004  
63
Antiplatelet therapy for preventing stroke and other vascular events after carotid endarterectomy.
[15060325] Stroke 35(5): 1227-8 (2004)
2004  
64
Antithrombotic drugs for carotid artery dissection.
[14739417] Stroke 35(2): 613-4 (2004)
2003  
65
Extracranial carotid artery stenosis.
[14563961] Stroke 34(11): 2767-73 (2003)
2003  
66
Systematic review of the risks of carotid endarterectomy in relation to the clinical indication for and timing of surgery.
[12920260] Stroke 34(9): 2290-301 (2003)
2003  
67
Revisiting the appropriateness of carotid endarterectomy.
[12738896] Stroke 34(6): 1464-71 (2003)
2003  
68
Duplex ultrasound and magnetic resonance angiography compared with digital subtraction angiography in carotid artery stenosis: a systematic review.
[12690221] Stroke 34(5): 1324-32 (2003)
2000  
69
The symptomatic carotid plaque.
[10700518] Stroke 31(3): 774-81 (2000)
1999  
70
Circle of Willis collateral flow investigated by magnetic resonance angiography.
[10582995] Stroke 30(12): 2671-8 (1999)
1999  
71
Carotid endarterectomy : where do we draw the line?
[10471418] Stroke 30(9): 1745-50 (1999)
1998  
72
Prognosis of patients with symptomatic vertebral or basilar artery stenosis. The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group.
[9660392] Stroke 29(7): 1389-92 (1998)
1997  
73
Symptomatic carotid artery occlusion. A reappraisal of hemodynamic factors.
[9341723] Stroke 28(10): 2084-93 (1997)
1996  
74
A systematic comparison of the risks of stroke and death due to carotid endarterectomy for symptomatic and asymptomatic stenosis.
[8571421] Stroke 27(2): 266-9 (1996)
1996  
75
A systematic review of the risks of stroke and death due to endarterectomy for symptomatic carotid stenosis.
[8571420] Stroke 27(2): 260-5 (1996)
1995  
76
Skepticism toward carotid ultrasonography. A virtue, an attitude, or fanaticism?
[7570718] Stroke 26(10): 1743-6 (1995)
1995  
77
Detection of carotid stenosis. From NASCET results to clinical practice.
[7631330] Stroke 26(8): 1325-8 (1995)
1995  
78
Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the ad hoc Committee, American Heart Association.
[7839390] Stroke 26(1): 188-201 (1995)
1988  
79
Reversible cerebral segmental vasoconstriction.
[3046073] Stroke 19(9): 1159-70 (1988)
1987  
80
Extracranial vertebral artery dissections: a review of 13 cases.
[3318002] Stroke 18(6): 1037-47 (1987)
1984  
81
Pathophysiology of extracranial cerebral arterial stenosis--a critical review.
[6367152] Stroke 15(2): 224-36 (1984)
1982  
82
Cervical arteriosclerosis--diagnostic advances in need of a clinical answer.
[6750861] Stroke 13(5): 551-6 (1982)
1982  
83
The natural history of asymptomatic carotid bifurcation plaques.
[7101345] Stroke 13(4): 459-64 (1982)
1982  
84
Asymptomatic carotid artery disease.
[7101341] Stroke 13(4): 431-3 (1982)
2000  
85
New developments in endovascular interventions for extracranial carotid stenosis.
[11093412] Tex Heart Inst J 27(3): 273-80 (2000)
1988  
86
Carotid endarterectomy: from first recorded case to present.
[15227240] Tex Heart Inst J 15(3): 139-41 (1988)
1993  
87
Carotid endarterectomy--the big picture.
[8351920] West J Med 159(1): 90-1 (1993)
1993  
88
Carotid endarterectomy for prevention of stroke.
[8351903] West J Med 159(1): 37-43 (1993)
1991  
89
[Analysis of Doppler sonographic findings in diabetic pregnancies].
[1790915] Gynakol Rundsch 31 Suppl 2(-): 169-73 (1991)
2007  
90
ACCF/SCAI/SVMB/SIR/ASITN 2007 clinical expert consensus document on carotid stenting: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting).
[17207736] J Am Coll Cardiol 49(1): 126-70 (2007)
2004  
91
Molecular regulation of vascular smooth muscle cell differentiation in development and disease.
[15269336] Physiol Rev 84(3): 767-801 (2004)
2004  
92
Molecular, endocrine, and genetic mechanisms of arterial calcification.
[15294885] Endocr Rev 25(4): 629-72 (2004)
2008  
93
Nanoscale architecture in atherosclerotic calcification.
[18946051] Arterioscler Thromb Vasc Biol 28(11): 1882-4 (2008)
2006  
94
Molecular mechanisms of vascular calcification: lessons learned from the aorta.
[16601233] Arterioscler Thromb Vasc Biol 26(7): 1423-30 (2006)
2005  
95
Inorganic pyrophosphate: a paracrine regulator of vascular calcification and smooth muscle phenotype.
[15790939] Arterioscler Thromb Vasc Biol 25(4): 651-4 (2005)
2004  
96
Vascular calcification: mechanisms and clinical ramifications.
[15155384] Arterioscler Thromb Vasc Biol 24(7): 1161-70 (2004)
2006  
97
Vascular calcification: pathobiological mechanisms and clinical implications.
[17095733] Circ Res 99(10): 1044-59 (2006)
2005  
98
Bone morphogenetic proteins in vascular calcification.
[16037577] Circ Res 97(2): 105-14 (2005)
2005  
99
Angiogenesis and pericytes in the initiation of ectopic calcification.
[15890980] Circ Res 96(9): 930-8 (2005)
2005  
100
Regulation of vascular calcification: roles of phosphate and osteopontin.
[15831823] Circ Res 96(7): 717-22 (2005)
2004  
101
Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin.
[15564564] Circ Res 95(11): 1046-57 (2004)
2004  
102
Pathophysiology of vascular calcification in chronic kidney disease.
[15375022] Circ Res 95(6): 560-7 (2004)
2008  
103
Vascular calcification: pathobiology of a multifaceted disease.
[18519861] Circulation 117(22): 2938-48 (2008)
2006  
104
Vitamin K epoxide reductase complex and vascular calcification: is this the important link between vitamin K and the arterial vessel wall?
[16567578] Circulation 113(12): 1550-2 (2006)
2008  
105
Accelerated atherosclerotic calcification and Monckeberg's sclerosis: a continuum of advanced vascular pathology in chronic kidney disease.
[18667741] Clin J Am Soc Nephrol 3(6): 1585-98 (2008)
2008  
106
Vitamin K-dependent proteins, warfarin, and vascular calcification.
[18495950] Clin J Am Soc Nephrol 3(5): 1504-10 (2008)
2008  
107
Mechanisms of vascular calcification in chronic kidney disease.
[18094365] J Am Soc Nephrol 19(2): 213-6 (2008)
2006  
108
Vascular calcifications: pathogenesis, management, and impact on clinical outcomes.
[17130273] J Am Soc Nephrol 17(12 Suppl 3): S267-73 (2006)
2004  
109
Vascular calcification mechanisms.
[15579497] J Am Soc Nephrol 15(12): 2959-64 (2004)
2009  
110
The emerging role of phosphate in vascular calcification.
[19145240] Kidney Int 75(9): 890-7 (2009)
2001  
111
Pathophysiological mechanisms of vascular calcification in end-stage renal disease.
[11473629] Kidney Int 60(2): 472-9 (2001)
2009  
112
Vascular and other tissue calcification in peritoneal dialysis patients.
[19270239] Perit Dial Int 29 Suppl 2(): S9-S14 (2009)
2007  
113
An overview of the pathophysiology of vascular calcification in chronic kidney disease.
[17556308] Perit Dial Int 27 Suppl 2(): S215-22 (2007)
2003  
114
Imaging of the vulnerable plaque: new modalities.
[14632365] South Med J 96(11): 1142-7 (2003)
2008  
115
Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
[18375475] QJM 101(7): 519-27 (2008)
2007  
116
Atherosclerosis imaging in statin intervention trials.
[17456609] QJM 100(5): 253-62 (2007)
2008  
117
From vulnerable plaque to atherothrombosis.
[18410594] J Intern Med 263(5): 506-16 (2008)
2004  
118
Pathologic assessment of the vulnerable human coronary plaque.
[15547008] Heart 90(12): 1385-91 (2004)
2003  
119
Basic aspects of plaque vulnerability.
[12975444] Heart 89(10): 1262-7 (2003)
2000  
120
Glagovian remodelling, plaque composition, and stenosis generation.
[11039994] Heart 84(5): 461-2 (2000)
1990  
121
Atherosclerosis and molecular pathology: mechanisms of cholesteryl ester accumulation in foam cells and extracellular space of atherosclerotic lesions.
[2290125] J Pharmacobiodyn 13(7): 385-413 (1990)
2008  
122
Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis.
[18218686] Cardiovasc Res 78(1): 8-17 (2008)
1999  
123
Mechanisms of plaque rupture: mechanical and biologic interactions.
[10341836] Cardiovasc Res 41(2): 369-75 (1999)
1999  
124
Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture.
[10341835] Cardiovasc Res 41(2): 361-8 (1999)
1999  
125
Fibrous cap formation or destruction--the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation.
[10341834] Cardiovasc Res 41(2): 345-60 (1999)
1999  
126
Atherosclerotic plaque rupture--pathologic basis of plaque stability and instability.
[10341833] Cardiovasc Res 41(2): 334-44 (1999)
1999  
127
Pathophysiology and clinical significance of atherosclerotic plaque rupture.
[10341832] Cardiovasc Res 41(2): 323-33 (1999)
1999  
128
Plaque instability--the real challenge for atherosclerosis research in the next decade?
[10341831] Cardiovasc Res 41(2): 321-2 (1999)
2005  
129
Inhibition and regression of atherosclerotic lesions.
[15940346] Acta Biochim Pol 52(2): 311-9 (2005)
2010  
130
Dynamic contrast enhanced (DCE) magnetic resonance imaging (MRI) of atherosclerotic plaque angiogenesis.
[20526859] Angiogenesis 13(2): 87-99 (2010)
2010  
131
Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions.
[20411320] Angiogenesis 13(2): 189-202 (2010)
2008  
132
Media calcification and intima calcification are distinct entities in chronic kidney disease.
[18815240] Clin J Am Soc Nephrol 3(6): 1599-605 (2008)
2005  
133
Novel determinants of plaque instability.
[16102103] J Thromb Haemost 3(9): 1962-75 (2005)
2005  
134
Vessel wall apoptosis and atherosclerotic plaque instability.
[15748235] J Thromb Haemost 3(3): 465-72 (2005)
2004  
135
The physiology of vitamin K nutriture and vitamin K-dependent protein function in atherosclerosis.
[15613016] J Thromb Haemost 2(12): 2118-32 (2004)
2004  
136
Mouse models of arteriosclerosis: from arterial injuries to vascular grafts.
[15215157] Am J Pathol 165(1): 1-10 (2004)
1998  
137
Risk factors and progression of atherosclerosis in youth. PDAY Research Group. Pathological Determinants of Atherosclerosis in Youth.
[9777934] Am J Pathol 153(4): 1023-33 (1998)
1977  
138
Structural changes within the media of coronary arteries related to intimal thickening.
[333934] Am J Pathol 89(1): 13-34 (1977)
1980  
139
Atherosclerosis. Regression in nonhuman primates.
[6766822] Circ Res 46(3): 311-20 (1980)
1995  
140
A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.
[7648691] Circulation 92(5): 1355-74 (1995)
1995  
141
Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics.
[7729036] Circulation 91(9): 2488-96 (1995)
2006  
142
Thematic review series: patient-oriented research. Imaging atherosclerosis: state of the art.
[16705212] J Lipid Res 47(8): 1677-99 (2006)
2004  
143
Thematic review series: The pathogenesis of atherosclerosis. Toward a biological network for atherosclerosis.
[15292376] J Lipid Res 45(10): 1793-805 (2004)
2002  
144
Atherogenesis--recent insights into basic mechanisms and their clinical impact.
[12454211] Nephrol Dial Transplant 17(12): 2055-64 (2002)
2008  
145
Age-related medial elastocalcinosis in arteries: mechanisms, animal models, and physiological consequences.
[18772323] J Appl Physiol 105(5): 1643-51 (2008)
2010  
146
Experimental atherosclerosis in rabbits.
[20857052] Arq Bras Cardiol 95(2): 272-8 (2010)
2008  
147
Risk factors for the development of atherosclerosis in childhood and adolescence.
[18516390] Arq Bras Cardiol 90(4): 276-283 (2008)
2009  
148
Mechanisms and consequences of efferocytosis in advanced atherosclerosis.
[19414539] J Leukoc Biol 86(5): 1089-95 (2009)
2009  
149
Translational mini-review series on immunology of vascular disease: accelerated atherosclerosis in vasculitis.
[19309350] Clin Exp Immunol 156(3): 377-85 (2009)
2010  
150
The expression and functions of toll-like receptors in atherosclerosis.
[20652007] Mediators Inflamm 2010(-): 393946 (2010)
2010  
151
Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells.
[20652043] Mediators Inflamm 2010(-): 174341 (2010)
2008  
152
Atherosclerosis as a disease of failed endogenous repair.
[18508460] Front Biosci 13(-): 3621-36 (2008)
2010  
153
ATP-binding membrane cassette transporter A1 (ABCA1): a possible link between inflammation and reverse cholesterol transport.
[20485864] Mol Med 16(9-10): 438-49 (2010)
2011  
154
Application of MRI to detect high-risk atherosclerotic plaque.
[21615314] Expert Rev Cardiovasc Ther 9(5): 545-50 (2011)
2008  
155
Hypothesis: arterial glycocalyx dysfunction is the first step in the atherothrombotic process.
[18319293] QJM 101(7): 513-8 (2008)
2003  
156
Tumor suppressor MDA-7/IL-24 selectively inhibits vascular smooth muscle cell growth and migration.
[12907144] Mol Ther 8(2): 220-9 (2003)
2009  
157
Valproate attenuates accelerated atherosclerosis in hyperglycemic apoE-deficient mice: evidence in support of a role for endoplasmic reticulum stress and glycogen synthase kinase-3 in lesion development and hepatic steatosis.
[19095952] Am J Pathol 174(1): 330-42 (2009)
2010  
158
Prelesional arterial endothelial phenotypes in hypercholesterolemia: universal ABCA1 upregulation contrasts with region-specific gene expression in vivo.
[19897713] Am J Physiol Heart Circ Physiol 298(1): H163-70 (2010)
2009  
159
Macrophage apoptosis in atherosclerosis: consequences on plaque progression and the role of endoplasmic reticulum stress.
[19243235] Antioxid Redox Signal 11(9): 2333-9 (2009)
2010  
160
The endoplasmic reticulum stress-C/EBP homologous protein pathway-mediated apoptosis in macrophages contributes to the instability of atherosclerotic plaques.
[20651282] Arterioscler Thromb Vasc Biol 30(10): 1925-32 (2010)
2006  
161
Nitric oxide and endoplasmic reticulum stress.
[16645155] Arterioscler Thromb Vasc Biol 26(7): 1439-46 (2006)
2012  
162
Macrophage autophagy plays a protective role in advanced atherosclerosis.
[22445600] Cell Metab 15(4): 545-53 (2012)
2010  
163
Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress.
[21035758] Cell Metab 12(5): 467-82 (2010)
2010  
164
Reduction of AMP-activated protein kinase alpha2 increases endoplasmic reticulum stress and atherosclerosis in vivo.
[20124121] Circulation 121(6): 792-803 (2010)
2007  
165
Increased endoplasmic reticulum stress in atherosclerotic plaques associated with acute coronary syndrome.
[17709641] Circulation 116(11): 1226-33 (2007)
2009  
166
Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications.
[19566488] Clin Sci (Lond) 117(3): 95-109 (2009)
2011  
167
Gene-activation mechanisms in the regression of atherosclerosis, elimination of diabetes type 2, and prevention of dementia.
[21568932] Curr Mol Med 11(5): 391-400 (2011)
2008  
168
Regulation of smooth muscle by inducible nitric oxide synthase and NADPH oxidase in vascular proliferative diseases.
[18211830] Free Radic Biol Med 44(7): 1232-45 (2008)
2009  
169
Tetrahydrobiopterin, superoxide, and vascular dysfunction.
[19628033] Free Radic Biol Med 47(8): 1108-19 (2009)
2010  
170
IGF-1, oxidative stress and atheroprotection.
[20071192] Trends Endocrinol Metab 21(4): 245-54 (2010)
2008  
171
Mechanisms of atherothrombosis in chronic obstructive pulmonary disease.
[18488431] Int J Chron Obstruct Pulmon Dis 3(1): 89-96 (2008)
2011  
172
Jeremiah Metzger Lecture: cholesterol, inflammation and atherosclerotic cardiovascular disease: is it all LDL?
[21686232] Trans Am Clin Climatol Assoc 122(-): 256-89 (2011)
2010  
173
Mechanisms of cell signaling by the scavenger receptor CD36: implications in atherosclerosis and thrombosis.
[20697562] Trans Am Clin Climatol Assoc 121(-): 206-20 (2010)
2010  
174
HDL apolipoprotein-related peptides in the treatment of atherosclerosis and other inflammatory disorders.
[20687877] Curr Pharm Des 16(28): 3173-84 (2010)
2009  
175
Rho kinase: an important mediator of atherosclerosis and vascular disease.
[19754385] Curr Pharm Des 15(27): 3108-15 (2009)
2010  
176
SIRT1/eNOS axis as a potential target against vascular senescence, dysfunction and atherosclerosis.
[20215708] J Atheroscler Thromb 17(5): 431-5 (2010)
2010  
177
Adipose tissue, inflammation and atherosclerosis.
[20124732] J Atheroscler Thromb 17(4): 332-41 (2010)
2010  
178
An update on the role of markers of inflammation in atherosclerosis.
[20032572] J Atheroscler Thromb 17(1): 1-11 (2010)
2009  
179
Apolipoprotein CIII links dyslipidemia with atherosclerosis.
[19262004] J Atheroscler Thromb 16(1): 6-11 (2009)
2008  
180
Antiatherogenic functionality of high density lipoprotein: how much versus how good.
[18385533] J Atheroscler Thromb 15(2): 52-62 (2008)
2009  
181
The high-risk thin-cap fibroatheroma: a new kid on the block.
[20031766] Circ Cardiovasc Interv 2(6): 500-2 (2009)
2008  
182
Intimal hyperplasia in murine models.
[18336244] Curr Drug Targets 9(3): 251-60 (2008)
2008  
183
Progression and disruption of advanced atherosclerotic plaques in murine models.
[18336239] Curr Drug Targets 9(3): 210-6 (2008)
2011  
184
The autoimmune concept of atherosclerosis.
[21881502] Curr Opin Lipidol 22(5): 327-34 (2011)
2008  
185
Emigration of monocyte-derived cells to lymph nodes during resolution of inflammation and its failure in atherosclerosis.
[18769227] Curr Opin Lipidol 19(5): 462-8 (2008)
2009  
186
Macrophage heterogeneity in atherosclerotic plaques.
[19741337] Curr Opin Lipidol 20(5): 370-8 (2009)
2009  
187
Atherosclerosis imaging: prognostically useful or merely more of what we know?
[19808581] Circ Cardiovasc Imaging 2(2): 150-60 (2009)
2010  
188
Apolipoprotein A-I and its mimetics for the treatment of atherosclerosis.
[20730693] Curr Opin Investig Drugs 11(9): 989-96 (2010)
2009  
189
Inflammation in atherosclerosis: from pathophysiology to practice.
[19942084] J Am Coll Cardiol 54(23): 2129-38 (2009)
2010  
190
Soluble epoxide hydrolase in atherosclerosis.
[20425256] Curr Atheroscler Rep 12(3): 174-83 (2010)
2010  
191
Insights into atherosclerosis using nanotechnology.
[20425261] Curr Atheroscler Rep 12(3): 209-15 (2010)
2010  
192
Recent developments with lipoprotein-associated phospholipase A2 inhibitors.
[20425270] Curr Atheroscler Rep 12(1): 43-7 (2010)
2007  
193
Cilostazol in the management of vascular disease.
[17353881] Int Angiol 26(1): 1-7 (2007)
2009  
194
Buflomedil: potential new indications for an old agent.
[19174750] Int Angiol 28(3): 170-4 (2009)
2010  
195
Monocytes in atherosclerosis: subsets and functions.
[20065951] Nat Rev Cardiol 7(2): 77-86 (2010)
2010  
196
Macrophage cholesteryl ester mobilization and atherosclerosis.
[19878739] Vascul Pharmacol 52(1-2): 1-10 (2010)
2010  
197
An approach to molecular imaging of atherosclerosis, thrombosis, and vascular inflammation using microparticles of iron oxide.
[19883911] Atherosclerosis 209(1): 18-27 (2010)
2008  
198
Ceramide: a common pathway for atherosclerosis?
[17963772] Atherosclerosis 196(2): 497-504 (2008)
2009  
199
YKL-40--an emerging biomarker in cardiovascular disease and diabetes.
[19930630] Cardiovasc Diabetol 8(-): 61 (2009)
2010  
200
Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis.
[20299739] J Med Invest 57(1-2): 12-25 (2010)
2011  
201
TGF-β and restenosis revisited: a Smad link.
[21324395] J Surg Res 167(2): 287-97 (2011)
2010  
202
Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis.
[19851078] J Vasc Res 47(2): 168-80 (2010)
2010  
203
Immunomodulation of vascular diseases: atherosclerosis and autoimmunity.
[20188603] Eur J Vasc Endovasc Surg 39(4): 485-94 (2010)
2009  
204
Controlling the angiogenic switch in developing atherosclerotic plaques: possible targets for therapeutic intervention.
[19946412] J Angiogenes Res 1(-): 4 (2009)
2009  
205
Novel markers of peripheral arterial disease.
[19808725] Vasc Med 14(4): 381-92 (2009)
2007  
206
Pathology of atherosclerosis and stenting.
[17826632] Neuroimaging Clin N Am 17(3): 285-301, vii (2007)
2011  
207
The role of peroxidases in the pathogenesis of atherosclerosis.
[21871172] BMB Rep 44(8): 497-505 (2011)
2009  
208
Innate and adaptive immunity in atherosclerosis.
[19449008] Semin Immunopathol 31(1): 5-22 (2009)
2010  
209
Clinical significance of the humoral immune response to modified LDL.
[19427818] Clin Immunol 134(1): 55-65 (2010)
2010  
210
Dendritic cells in atherosclerotic disease.
[19520615] Clin Immunol 134(1): 25-32 (2010)
2010  
211
Innate immunity in atherosclerosis.
[20505313] J Innate Immun 2(4): 305-6 (2010)
2010  
212
Emerging role of IL-17 in atherosclerosis.
[20505315] J Innate Immun 2(4): 325-33 (2010)
2010  
213
Dendritic cells and their role in atherogenesis.
[20458277] Lab Invest 90(7): 970-84 (2010)
2005  
214
The role of shear stress in the pathogenesis of atherosclerosis.
[15568038] Lab Invest 85(1): 9-23 (2005)
2010  
215
Gene activation regresses atherosclerosis, promotes health, and enhances longevity.
[20604930] Lipids Health Dis 9(-): 67 (2010)
2010  
216
STIM and Orai proteins: players in sexual differences in hypertension-associated vascular dysfunction?
[20001956] Clin Sci (Lond) 118(6): 391-6 (2010)
2005  
217
Pathway analysis of coronary atherosclerosis.
[15942018] Physiol Genomics 23(1): 103-18 (2005)
2007  
218
Genetic and genomic insights into the molecular basis of atherosclerosis.
[17767904] Cell Metab 6(3): 164-79 (2007)
PMC   
219
Altered expression of Raet1e, a major histocompatibility complex class 1-like molecule, underlies the atherosclerosis modifier locus Ath11 10b.
[23948654] Circ Res 113(9):1054-64 (2013)
PMC   
220
A major role for RCAN1 in atherosclerosis progression.
[24127415] EMBO Mol Med 5(12):1901-17 (2013)
PMC   
221
Dendritic cells and regulatory T cells in atherosclerosis.
[22752759] Mol Cells 34(4):341-7 (2012)
PMC   
222
Local proliferation dominates lesional macrophage accumulation in atherosclerosis.
[23933982] Nat Med 19(9):1166-72 (2013)
PMC   
223
Inflammation and diabetes-accelerated atherosclerosis: myeloid cell mediators.
[23153419] Trends Endocrinol Metab 24(3):137-44 (2013)
PMC   
224
Protective Role for Properdin in Progression of Experimental Murine Atherosclerosis.
[24667818] PLoS One 9(3): (2014)
PMC   
225
Thrombin inhibition by dabigatran attenuates atherosclerosis in ApoE deficient mice.
[24701228] Arch Med Sci 10(1):154-60 (2014)
PMC   
226
AIP1 suppresses atherosclerosis by limiting hyperlipidemia-induced inflammation and vascular endothelial dysfunction.
[23413429] Arterioscler Thromb Vasc Biol 33(4):795-804 (2013)
PMC   
227
Advances in molecular imaging of atherosclerotic vascular disease.
[18830079] Curr Opin Cardiol 23(6):620-8 (2008)
PMC   
228
Persistent C. pneumoniae infection in atherosclerotic lesions: rethinking the clinical trials.
[24711989] Front Cell Infect Microbiol 4():34 (2014)
PMC   
229
Cooling the fire of atherosclerosis with heat shock protein 27.
[23747762] J Am Coll Cardiol 62(16):1455-6 (2013)
PMC   
230
Macrophage lipoprotein lipase modulates the development of atherosclerosis but not adiposity.
[23378601] J Lipid Res 54(4):1124-34 (2013)
PMC   
231
Bone marrow stem cell injection for the treatment of critical limb ischemia.
[24693015] J Stem Cells Regen Med 3(1):15-8 (2007)
PMC   
232
Advances in immune-modulating therapies to treat atherosclerotic cardiovascular diseases.
[24757525] Ther Adv Vaccines 2(2):56-66 (2014)
PMC   
233
Hypoxia in murine atherosclerotic plaques and its adverse effects on macrophages.
[23375596] Trends Cardiovasc Med 23(3):80-4 (2013)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia